Contrast Ultrasound in the Surveillance of Endovascular Abdominal Aortic Aneurysm Repair
NCT ID: NCT01022892
Last Updated: 2012-03-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
140 participants
OBSERVATIONAL
2009-09-30
2012-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators' primary goal is to detect no difference between CT and CUS and provide evidence that CUS is a possible alternative to CT.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Contrast-Enhanced Ultrasound to Detect Endoleaks After Endovascular Aortic Aneurysm Repair
NCT01005212
Contrast Ultrasound Assessment of Perfusion Changes After Peripheral Artery Revascularization
NCT02877563
Ultrasound to Predict the Prognosis of Rotator Cuff Tears
NCT04601623
Fluorescent Imaging & Methylene Blue: Ureter Study
NCT03177070
Diagnostic Value of Compression Ultrasound to Detect Acute Compartment Syndrome After Lower Limb Revascularisation
NCT04806555
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Phase 1 - Pilot phase
Total of 10 patients currently undergoing EVAR Surveillance. These 10 patients include 5 patients with endoleak known from a recent CT scan and 5 patients with no endoleak and shrinking aneurysm.
No interventions assigned to this group
Phase 2 - Blinded from CT Scan
This phase of study involves recruitment of 150 patients currently under post-EVAR surveillance. The physicians and ultrasound technologists will be blinded to the result of the CT Scan when performing and interpreting the CUS. The current schedule for EVAR Surveillance will be maintained so that an individual may receive more than one enhanced CT Scan and CUS during the 18 months of the study.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Unable to acquire IV access
* Right-to-left, bi-directional, or transient right-to-left cardiac shunts
* Severe pulmonary disease
* Previous hypersensitivity to DEFINITY® or its components
* Unable to be followed as a outpatient by the Vascular Diagnostic Center
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ottawa Hospital Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Sudhir Nagpal
Vascular Surgeon
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sudhir Nagpal, MD
Role: PRINCIPAL_INVESTIGATOR
The Ottawa Hospital - Division of Vascular & Endovascular Surgery
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2007607-01H
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.